CellMosaic is a bio-technology company empowered by its proprietary AqueaTether (AqT) technologies and advanced bio-conjugation processes. 

Since its establishment in 2008, CellMosaic has invested significant research efforts into developing these proprietary technologies, enabling us to offer innovative bioconjugate products and kits for customers to produce high-quality advanced bioconjugates. We also provide services & manufacturing for custom bioconjugates and collaborate with partners to develop AqT-based bioconjugates and antibody-drug conjugates (ADCs).